Home › Calculator › DMPHF Dividend Calculator 2026
DMPHF Dividend DRIP Calculator 2026
1.90% YieldHealthcareDermapharm Holding SE · OTC
Price: $53.00 · Annual div: $1.01/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When DMPHF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your DMPHF snowball 📈
$10,000 in DMPHF → $489.1K in 10 years · $54.31/month
About Dermapharm Holding SE (DMPHF) — Dividend Analysis 2026
Dermapharm Holding SE is an international pharmaceutical company specializing in off-patent branded medications, serving both domestic and global markets. Its business is structured across three distinct segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Imports, and Herbal Extracts. The company's comprehensive activities encompass the development, production, licensing, marketing, and distribution of its offerings. Its product range includes reputable generic drugs, non-prescription remedies, natural over-the-counter treatments, and a variety of other health products. These target diverse medical fields, such as vitamin and mineral supplementation, nutritional support, skin conditions (dermatology), allergies, pain relief, cardiovascular health, women's health (gynecology), and urological issues. Key brands in its portfolio feature Dekristol, Dekristolvit, Allergovit, and Tromcardin. Additionally, Dermapharm provides medical devices like bite away and Herpotherm, alongside specific treatments such as the Momekort nasal spray for allergy symptoms and Azedil, available as a nasal spray or eye drops. Within its Parallel Imports division, Dermapharm brings original pharmaceuticals to market under the axicorp brand. The Herbal Extracts segment supplies natural active ingredients and botanical extracts primarily for phytopharmaceuticals, nutraceuticals, and cosmetic applications. The company's distribution network reaches pharmaceutical wholesalers, individual pharmacies, hospitals, and health food stores. Founded in 1991 and headquartered in Grünwald, Germany, Dermapharm Holding SE operates as a subsidiary of Themis Beteiligungs-Aktiengesellschaft.
Compare DMPHF with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full DMPHF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open DMPHF position with:
🌍 DMPHF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold DMPHF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 1.90% | -0.90% | $190 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 1.61% | -1.18% | $162 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 1.52% | -1.28% | $152 / yr |
| 🇬🇧 UK ISA | 0% | 1.90% | -0.90% | $190 / yr |
| 🇬🇧 UK Taxable | 8.75% | 1.73% | -1.07% | $173 / yr |
| 🇨🇦 TFSA | 0% | 1.90% | -0.90% | $190 / yr |
| 🇨🇦 CA Taxable | 25% | 1.42% | -1.38% | $143 / yr |
| 🇦🇺 Super (pension) | 15% | 1.61% | -1.18% | $162 / yr |
| 🇦🇺 AU Taxable | 30% | 1.33% | -1.47% | $133 / yr |
| 🇩🇪 DE Taxable | 26.375% | 1.40% | -1.40% | $140 / yr |
| 🇫🇷 FR Taxable | 30% | 1.33% | -1.47% | $133 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 DMPHF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $1.01/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 DMPHF Dividend Payment Schedule
DMPHF pays quarterly — 4 times per year. Next ex-div: TBD.
📊 DMPHF vs Healthcare Benchmarks
How DMPHF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for DMPHF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ DMPHF Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the DMPHF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Dermapharm Holding SE (DMPHF) is currently trading at $53.00, trading near its 52-week high. The current dividend yield is 1.90% based on an annual payout of $1.01 per share.
DMPHF (Dermapharm Holding SE) — 1.90% Dividend Yield Analysis
Dermapharm Holding SE (DMPHF) is a healthcare stock currently trading at $53.00 with a dividend yield of 1.90%. The company pays an annual dividend of $1.01 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, DMPHF has grown its dividend at a compound annual rate of 12.5%.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest DMPHF News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.